08/04/2026
🧬 The Rise of Minor Cannabinoids
Beyond THC and CBD, researchers are studying how cannabinoids like CBN, THCV, CBG and CBDV may offer targeted therapeutic benefits, opening the door to condition-specific formulations.
Early studies suggest these compounds interact with the body in distinct ways, influencing inflammatory pathways, neurological signalling, and overall endocannabinoid balance.
While clinical evidence is still emerging, interest is growing in how minor cannabinoids may support more targeted, condition-specific formulations, reinforcing the shift toward personalised, evidence-led medical cannabis care.
Sources:
https://pmc.ncbi.nlm.nih.gov/articles/PMC8669157/
https://norml.org/news/2022/01/06/review-minor-cannabinoids-acknowledged-to-possess-therapeutic-properties/